Video

Andrew J. Cutler, MD: Screening Techniques for ADHD

Author(s):

Attempts to use neuroimaging to screen for ADHD in the past have failed.

Screening for attention deficit/hyperactivity disorder (ADHD) has not changed much over the years.

Often the screening practices include a self-screening questionnaire to help the patient recognize the signs and symptoms of ADHD. For adolescent ADHD patients, the screening process can also include interviews from teachers, family members, and other people.

While there are tools to help the psychiatry screen patients for the disorder, a high degree of suspicion remains the most important aspect of screening for ADHD.

Doctors will look to find out not only about the individual symptoms each patient must have, but also how these symptoms might impact their lives. For example, ADHD is known to have an impact on an individual’s school or work function, so to be diagnosed and treated for ADHD most patients can readily have an example of how those functions have been impacted.

In an interview with HCPLive®, Andrew, J. Cutler, MD, Clinical Professor of Psychiatry at SUNY Upstate Medical University, explained why screening practices are effective and why there is some hope for new techniques and technologies to make an impact in the future.

Cutler said right now there is no biomarkers or clinically relevant sensitivity testing useful and accurate enough to be used on the widescale for ADHD.

Related Videos
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Christian T. Ruff, MD, MPH: Abelacimab Cuts Bleeding Risk Versus Rivaroxaban| Image Credit: Brigham & Women's Hospital
Barry A. Borlaug, MD: Impact of Tirzepatide on Cardiorenal End-Organ Damage | Image Credit: Mayo Clinicn HFpEF
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Minjee Kim, MD: Understanding Sleep’s Impact on Post-Liver Transplant Outcomes
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
Chari Cohen, DrPH, MPH | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.